-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse FrankfurtEURSymbol TEV-
Teva PharmaceuticalBörse Börse FrankfurtEURSymbol TEV
-
TEVA PHARMACEUTICAL-SP ADRBörse Börse HamburgEURSymbol TEV
-
TEVA PHARMACEUTICAL-SP ADRBörse Gettex System der Börse MünchenEURSymbol TEV
-
TEVA PHARMACEUTICAL-SP ADRBörse Börse BerlinEURSymbol TEV
-
TEVA PHARMACEUTICAL-SP ADRBörse Börse MünchenEURSymbol TEV
-
TEVA PHARMACEUTICAL-SP ADRBörse Börse StuttgartEURSymbol TEV
-
TEVA PHARMACEUTICAL-SP ADRBörse Börse DüsseldorfEURSymbol TEV
-
TEVA PHARMACEUTICAL-SP ADRBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol TEV
-
TEVA PHARMACEUTICAL-SP ADRBörse Quotrix System der Börse DüsseldorfEURSymbol TEV
-
Teva PharmaceuticalBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"ISIN US8816242098 WKN: 883035USDSymbol TEVA
-
TEVA PHARMACEUTICAL INDUSTRIES LTDBörse NYSE New York Stock ExchangeUSDISIN IL0006290147 WKN: 906517
-
Teva PharmaceuticalBörse NYSE New York Stock ExchangeISIN US8816242098 WKN: 883035Symbol TEVA
-
MXNTEVA PHARMACEUTICAL INDUSTRIESBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
TEVA PHARMACEUTICAL INDUSTRIESBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
Teva PharmaceuticalBörse TLV
-
Teva PharmaceuticalBörse Freiverkehr OTC
-
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
12.562.424.832 oder 8.585.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
40.039 oder 34.004 Mitarbeiter
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 9,29 USD +1,08%
Aktionärsstruktur der Teva Pharmaceutical Industries Limited
Portrait der Teva Pharmaceutical Aktie
Das Unternehmen Teva Pharmaceutical Industries Limited aus Israel beschäftigt 37.022 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Das Unternehmen Teva Pharmaceutical Industries Limited ist in ungefähr 14 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter iShares TA-35 Israel UCITS ETF gewichtet Teva Pharmaceutical mit 7,01% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Teva Pharmaceutical Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Teva Pharmaceutical Industries Limited am höchsten gewichtet ist Insgesamt in 14 ETFs enthalten
Dir gefallen die Informationen zu Teva Pharmaceutical?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Teva Pharmaceutical?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Teva Pharmaceutical?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Teva Pharmaceutical?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
48 News & Informationen zur Teva Pharmaceutical Aktie
Do Hedge Funds Love Textron Inc. (TXT)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
Non-opioid Pain Treatment Market Size to Grow at a CAGR of 16.8% from 2021 to 2030
The global non-opioid pain treatment market valued at USD 13,200.6 million in 2020, and it is projected to grow at a CAGR of 16.8 % during the forecast…
U.S. OTC Drugs Market Size to Reach Revenues USD 43.18 Billion by 2026
/PRNewswire/ — In-depth analysis and data-driven insights on the impact of COVID-19 included in this U.S. OTC drugs market report. The U.S. OTC drugs market…
Hedge Funds Are Dumping F5 Networks, Inc. (FFIV)
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting…
Will Teva Stock Rebound After A 10% Fall In A Month?
We believe that Teva Pharmaceutical stock is a good buying opportunity at the present time. TEVA stock trades near $10 currently and it is, in fact, down 28% from its pre-Covid high of around $13 in Feb 2020 – before the coronavirus pandemic hit the world. TEVA stock has had a volatile ride since…
Teva Pharmaceutical Industries : Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements with Certain Officers (Form 8-K)
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements with Certain… | July 6, 2021
Warren Buffett’s 6 Worst-Performing Stocks in Q2 – 24/7 Wall St.
Six of the stocks in Berkshire Hathaway's portfolio posted losses in the second quarter. Here is how they fared.
Teva To Host Conference Call To Discuss Second Quarter 2021 Financial Results At 8 A.m. ET On July 28, 2021
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its financial results for the second quarter of
Here’s How Warren Buffett’s Portfolio Jumped Almost 10% in Q2 – 24
Warren Buffett's stock portfolio increased by $26.8 billion in the second quarter. Here's how.
Teva Pharmaceutical Industries Stock Is Estimated To Be Modestly Undervalued
GuruFocus Article or News written by GF Value and the topic is about:
New York takes Teva, McKesson, others to trial over opioids By Reuters
New York takes Teva, McKesson, others to trial over opioids
PRESS RELEASE: Teva Pharmaceutical Industries Ltd. becomes strategic partner for the commercialization of FYB201, Formycon's biosimilar candidate to Lucentis(R)1 (ranibizumab) in Europe, Canada, Israe
DGAP-News: Formycon AG / Key word: Alliance/Contract
Teva Pharmaceutical Industries Ltd. becomes strategic partner for the commercialization of FYB201, Formycon's
biosimilar candidate to Lucentis1 … | June 28, 2021
5 Buffett Stocks to Buy Hand Over Fist for the Second Half of 2021
These growth and value stocks are begging to be bought by investors.
The Worldwide Cryptococcosis Treatment Industry is Expected to Reach $6 Billion by 2026 at a CAGR of 4.5% from 2021
/PRNewswire/ — The “Global Cryptococcosis Treatment Market (2021-2026) byTreatment, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff…
Teva Pharmaceutical Industries : Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced its U.S. launch of the first generic version of twice daily PERFOROMIST®, formoterol fumarate… | June 22, 2021
Drug companies to face first opioid trial following pandemic delays By Reuters
Drug companies to face first opioid trial following pandemic delays
Preterm Birth Prevention and Management Market to See over 9% CAGR Through 2029
Major healthcare providers continue to use progesterone therapy extensively. However, such preventative medication is expected to decline over concerns of
Outlook On The End Stage Renal Disease Global Market To 2025 – Competitive Analysis And Impact Of COVID-19
DUBLIN, April 13, 2021 /PRNewswire/ — The “Global End Stage Renal Disease Market (2020-2025) by Disease Type, Treatment Type, End User, Geography, Competitive
Welcome to the Roaring ’20s, but Maybe Not for Stocks
The 10 investment pros on the Barron’s Roundtable see the U.S. economy growing 4% to 6% this year as Covid is defeated. But lofty valuations could limit the market’s gains. Plus, 9 picks from Bill Priest and Meryl Witmer
Stocks making the biggest moves in the premarket: JPMorgan Chase, PNC Financial, Disney & more
The stocks making the biggest moves in premarket trading include JPMorgan Chase, PNC Financial, Disney, and more.
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 39th Annual JP Morgan Healthcare Conference Transcript
Teva Pharmaceutical Industries Limited's (TEVA) CEO Kåre Schultz on 39th Annual JPMorgan Healthcare Conference (Transcript)
Opioid Use Disorder Market Worth USD 4.87 Billion at 8.7% CAGR by 2027 Backed by Increasing Number of Opioid Dependence Patients in North America
Pune, India, Jan. 13, 2021 (GLOBE NEWSWIRE) — The global opioid use disorder market is expected to experience exponential growth by reaching USD 4.87 …
5 Buffett-Aktien, die 2021 starke Käufe sind
Diese bewährten Buffett-Aktien sind für jedes Portfolio geeignet.
Regeneron Pharmaceuticals : Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses
TARRYTOWN, N.Y., Jan. 12, 2021 /PRNewswire/ –?
New agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing total potential U.S. supply to… | January 12, 2021
Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses
TARRYTOWN, N.Y., Jan. 12, 2021 /PRNewswire/ —
New agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, …
A leading Wall Street firm asked 7 famous investors about their favorite stocks and the global trades they're using to stay ahead of the competition. Here's what they're betting on now.
John Rogers' flagship Ariel Fund was at one time the best of the 2010s bull market. Danny Moloshok/Reuters A crew of the most famous cheap…
A leading Wall Street firm asked 7 famous investors about their favorite stocks and the global trades they're using to stay ahead of the competition. Here's what they're betting on now.
Seven of the most successful value investors in the world shared their stock picks and favorite industries in an Ariel Investments webchat.
Israel stocks higher at close of trade; TA 35 up 1.67% By Investing.com
Israel stocks higher at close of trade; TA 35 up 1.67%
8 Aktien, die 2021 das Investment verdoppeln könnten
Dreistellige Renditen könnten bloß einen Klick entfernt sein.
Global Active Pharmaceutical Ingredients Market Report 2020: Data from 2018, 2019, Estimates for 2020 and Projection of CAGR through 2025
DUBLIN, Jan. 8, 2021 /PRNewswire/ — The 'Active Pharmaceutical Ingredients: Global Markets' report has been added to ResearchAndMarkets.com's off…
Global Active Pharmaceutical Ingredients Markets Report 2020 with Profiles of Actavis, BASF, Cambrex, GlaxoSmithKline and Sun Pharmaceutical Industries
Dublin, Jan. 06, 2021 (GLOBE NEWSWIRE) — The “Active Pharmaceutical Ingredients: Global Markets” report has been added to …
Global Oncology Precision Medicine Market (2020 to 2030) – Analysis and Forecast
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) — The “Global Oncology Precision Medicine Market: Focus on Application Area, Ecosystem Type, Country Data (15 …
Outlook on the Hydroxychloroquine Global Market to 2027 – Opportunity Analysis and Industry Forecast
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) — The “Hydroxychloroquine Market by Product type, Distribution Channel, and Disease: Global Opportunity Analysis …
Worldwide Industry for Respiratory Inhaler Devices to 2025 – Widespread Rise in Chronic Respiratory Diseases Presents Opportunities
/PRNewswire/ — The “Global Respiratory Inhaler Devices Market (2020-2025) by Product, Technology, End-User, Disease Indication and Geography and the Impact of…
Worldwide Industry For Respiratory Inhaler Devices To 2025 – Widespread Rise In Chronic Respiratory Diseases Presents Opportunities
DUBLIN, Jan. 4, 2021 /PRNewswire/ — The “Global Respiratory Inhaler Devices Market (2020-2025) by Product, Technology, End-User, Disease Indication and
Billionaire David Abrams’ Top 10 Stock Picks
The value investing guru David Abrams is one of the most successful hedge fund managers over the last two decades, thanks to his strategy of buying undervalued…
Drugmakers Raise Prices 3.3% in the New Year
Prices of hundreds of drugs rose on average by 3.3%, according to an analysis of about 70 companies. The rate was lower than last year’s increases.
3 Top-Aktien, die zu unter 5 Dollar pro Aktie gehandelt werden
Diese günstigen Aktien können noch richtig weit wachsen.